Biota Pharmaceuticals (BOTA) Reports Q4 Loss of $0.29/Share

Biota Pharmaceuticals (NASDAQ: BOTA) reported Q4 EPS of ($0.29), versus ($0.23) reported last year. Revenue for the quarter came in at $8.5 million, versus $9.3 million reported last year.

For earnings history and earnings-related data on Biota Pharmaceuticals (BOTA) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid